Covid-19 vaccination drive starts in Assam
Guwahati/UNI: The Covid-19 vaccination drive started in Assam on Saturday along with other parts of the country.
Congress MP Manish Tewari questions roll out of Covaxin
New Delhi/IBNS: Congress leader Manish Tewari has raised questions over unavailability of options in choosing the Coronavirus vaccine, according to media reports.
Covid-19: Bharat Biotech rolls out India's indigenous vaccine Covaxin
Hyderabad/IBNS: A day after the Serum Institute of India (SII) rolled out its vaccine against Covid-19, the first batch of India's indigenous remedy Covaxin, made by Bharat Biotech, left Hyderabad for 11 cities on Wednesday morning, media reports said.
Bharat Biotech announces completion of phase 3 clinical trials of Covid-19 vaccine
New Delhi/UNI: Bharat Biotech on Thursday announced that it has enrolled 25,800 volunteers for phase 3 clinical trials of its indigenously manufactured Covid-19 vaccine, 'Covaxin'.
New Delhi/IBNS: Chairman of Bharat Biotech- whose coronavirus vaccine Covaxin has been permitted for "restricted use in an emergency situation in public interest"- on Monday hit out at its critics and said 'don't accuse us of inexperience.'
Expert panel recommends approval for Bharat Biotech's Covaxin
New Delhi/IBNS: A government-appointed panel of experts on Saturday cleared emergency use of indigenous COVID-19 vaccine Covaxin manufactured by Hyderabad-based Bharat Biotech, which will be sent for approval to the regulator Drugs Controller General of India (DCGI).
Govt's expert panel clears Oxford COVID-19 vaccine for India
New Delhi/IBNS: A government-appointed panel of experts on Friday cleared the Oxford COVID-19 vaccine manufactured by the Serum Institute of India, which will be sent for approval to the regulator Drugs Controller General of India (DCGI).
Govt's expert panel to meet over Covid-19 vaccine approval today
New Delhi/IBNS: An expert panel, appointed by the central government, will on Friday meet over the approval for an emergency use of three Covid-19 vaccines, including an indigenous one.
After Pfizer and Serum Institute, Bharat Biotech seeks DCGI approval for emergency use of Covaxin
New Delhi/IBNS: After Pfizer and Serum Institute, Hyderabad-based pharmaceutical company Bharat Biotech has sought approval from the Drug Controller General of India (DCGI) for the emergency use authorisation (EUA) of its Covid-19 vaccine-Covaxin, media reports said.
India's Covid-19 vaccine candidate 'Covaxin' gets clearance for Phase 3 clinical trials
New Delhi/IBNS: In a ray of hope, India's coronavirus vaccine named 'Covaxin', being developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR), has been cleared for the third phase of clinical trials.
Bharat Biotech's vaccine candidate shows 'robust immune responses' in animal study
New Delhi/IBNS: Bharat Biotech that has been working on coronavirus vaccine COVAXIN has said a study on animals has shown that the vaccine candidate has helped develop a strong immune response to the highly infectious pathogen.
First phase trial of India's COVID-19 vaccine Covaxin begins on 375 people: Report
New Delhi: India's Bharat Biotech International Limited, which claimed to have created the country's first potential indigenous coronavirus disease (Covid-19) vaccine, has said the first phase of testing it on 375 people has started, media reports said.
'Process as per global norms': ICMR defends Aug 15 deadline for COVAXIN
New Delhi/IBNS: The Indian Council of Medical Research (ICMR) has defended the August 15 launch of COVAXIN, after the scientific community of the country termed the short timeline "risky" and "impossible", a media report said.
India aims to launch indigenous Covid-19 vaccine by Aug 15 with ICMR partnering with Bharat Biotech
New Delhi/IBNS: The Indian Council of Medical Research (ICMR) has partnered with Bharat Biotech International Limited (BBIL) to fast-track the clinical trials of Covid-19 vaccine, giving India a chance to come up with its indigenous cure for the deadly virus, media reports said.
India's first COVID-19 vaccine gets DCGI's approval for human trials: Report
Hyderabad/IBNS: India's first homegrown Covid-19 vaccine candidate COVAXIN has received approval from Drug Controller General of India (DCGI) to conduct Phase I and II human trials, said a media report.